Position Paper: Differential Features of Beta- Adrenoreceptor Blocking Drugs for Therapy
More than 30 years ago, in studying the effects of six sympathomimetic amines on a variety of effector systems, Ahlquist (1) classified adrenore-ceptors into two distinct types: alpha-receptors, whose stimulation produces excitatory responses, and beta-receptors, whose activation results in in-hibitory responses plus cardiac stimulation. Beta- receptors have been further classified into betai-receptors (which occur chiefly in the heart) and beta2-receptors (which occur elsewhere) (2). The distribution of adrenoreceptors is shown in Table 1, although it now appears that more than one type of beta-receptor may 1, although it now appears that more than one type of beta-receptor may be present both in the heart and in the lung (3).
KeywordsBlocking Drug Renin Release Partial Agonist Activity Ceptor Antagonist Plasma Free Fatty Acid Level
Unable to display preview. Download preview PDF.
- 1.Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol (Lond) 153: 586 - 600Google Scholar
- 4.Powell CB, Slater IH (1958) Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. Pharmacol Exp Ther 122: 480–488Google Scholar
- 5.Barrett AM (1973) Beta-adrenoceptive antagonists: In: Hamer J (ed) Recent advances in cardiology. Churchill Livingstone, Edinburgh and London, p 289Google Scholar
- 6.Morales-Aguilera A, Vaughan-Williams EM (1965) The effects on cardiac muscle of ß-receptor antagonists in relation to their activity as locak anaesthetics. Br J Pharmacol 24: 332–338Google Scholar
- 7.Coltart DJ, Meldrum SJ (1970) The effect of pro-pranolol on the human and canine transmembrane action potential. Br J Pharmacol 40: 148 PGoogle Scholar
- 10.Gibson (1977) Pharmacodynamic properties of ß- adrenoceptor blocking drugs in man. In: Avery GS (ed) Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics. Publishing Services Group, Acton, Mass.Google Scholar
- 11.Franciosa JA, Johnson SM, Tobian LJ (1980) Haemodynamic effects of oxprenolol and propranolol in hypertension. Clin Pharmacol Ther 26: 676–681Google Scholar
- 15.Christenson CC, Boye NP, Erikson H, Hansen G (1978) Influence of pindolol ( Visken) on respiratory function. Eur J Pharmacol 13: 9–12Google Scholar
- 21.Formgren H (1976) The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. Br J Clin Pharmacol 3: 1007–1014Google Scholar
- 22.Davidson N McD, Corrall RJM, Shaw TRD, French EB (1976) Observations in man of hypogly- caemia during selective and non-selective beta- blockade. Scot Med J 22: 69–72Google Scholar
- 27.Shand DG (1977) Pharmacokinetic properties of the ß-adrenoceptor blocking drugs. In: Avery GS (ed) Cardiovascular drugs, Adis Press, Sydney (ß- Adrenoceptor blocking drugs, Vol 2, pp 41–54 )Google Scholar
- 29.Salem SAM, McDevitt DG (1980) Central effects of atenolol in man. Clin Pharmacol Ther 27: 283Google Scholar